Ian Gilham

Ian David Gilham is currently Chairman at Lifearc since 2023, Non-Executive Chairman at Cytox Ltd., Non-Executive Chairman at Pelago Bioscience AB, Director at Stowheath Ltd. since 2011, Director at Revona Bio Ltd. since 2023, and Non-Executive Director at Novacyt SA starting in 2024.
Former roles include Chief Executive Officer at Axis-Shield Ltd. in 2012, Chairman at Revvity Discovery Ltd. in 2013, Non-Executive Chairman at Multiplicom NV from 2013 to 2017, Non-Executive Chairman at Horizon Discovery Group Ltd. from 2014 to 2020, Executive Chairman at Aptamer Group Plc in 2023, Non-Executive Chairman at Biosurfit SA, Non-Executive Chairman at Genedrive Plc from 2016 to 2026, Independent Non-Executive Director at Ligand UK Ltd. from 2015 to 2018, Director at Fortis Cardiff Ltd. from 2013 to 2016, Non-Executive Director at Delta Diagnostics (UK) Ltd. from 2017 to 2019, Vice President-Pharmacogenetics & Diagnostics at GSK Plc, and Principal at GE Healthcare Ltd. (United Kingdom), Abbott Laboratories Ltd., and Celltech Ltd. Education includes a doctorate from the University of Bath and an undergraduate degree from The University of Wales.